AI biomolecular design startup Boltz raises $110M Series A led by Bessemer
GabriCorso · x · 2026-11-19
AI biomolecular design company Boltz announced a $110M Series A led by Besmer VP.
- Molecular token usage from users grew 50-fold since June
- Partnerships with 6 of the world's 20 largest pharma companies
- Funding will bring AI-powered biomolecular design to more scientists driving early-stage drug discovery
Related event: AI Drug Design Firm Boltz Raises $110M Series A(34 posts)→
More from Venture
- Listicle scaling doesn't last: SEOs watch mass-produced listicles lose rankings — gaganghotra_ · 2026-11-19
- Agentcard raises $8M to let agents buy from 5,000+ stores via Stripe Link — jeff_weinstein · 2026-11-19
- Anthropic's IPO is tomorrow, and San Francisco is already celebrating the liquidity event — nmasc_ · 2026-11-19
- Vercel crosses $700M annualized revenue, up 180% YoY, as agents drive deployments — cramforce · 2026-11-19
- Google manual actions surge: risky GEO/AEO tactics triggering scaled content abuse penalties — gaganghotra_ · 2026-11-19
- Nvidia to buy $10B in Anthropic shares, sparking joking "coup plot" narratives — StewartalsopIII · 2026-11-19